Determination of BCR_ABL breakpoint in chronic myelogenous leukemia patients (2002)
Zyngier, Szulim Ber; Castro, N S.; Ferro, Emer Suavinho 
; Barros, J C A.
Source: Meeting abstracts. Conference titles: World Congress of Pharmacology. Unidade: ICB
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZYNGIER, Szulim Ber et al. Determination of BCR_ABL breakpoint in chronic myelogenous leukemia patients. 2002, Anais.. San Francisco: Instituto de Ciências Biomédicas, Universidade de São Paulo, 2002. . Acesso em: 20 jun. 2024.APA
Zyngier, S. B., Castro, N. S., Ferro, E. S., & Barros, J. C. A. (2002). Determination of BCR_ABL breakpoint in chronic myelogenous leukemia patients. In Meeting abstracts. San Francisco: Instituto de Ciências Biomédicas, Universidade de São Paulo.NLM
Zyngier SB, Castro NS, Ferro ES, Barros JCA. Determination of BCR_ABL breakpoint in chronic myelogenous leukemia patients. Meeting abstracts. 2002 ;[citado 2024 jun. 20 ]Vancouver
Zyngier SB, Castro NS, Ferro ES, Barros JCA. Determination of BCR_ABL breakpoint in chronic myelogenous leukemia patients. Meeting abstracts. 2002 ;[citado 2024 jun. 20 ]
